Stroke is a leading cause of disability and death worldwide. Early recognition and prompt management can significantly improve patient outcomes. This article aims to provide healthcare professionals with a comprehensive guide to early stroke recognition and management.
Stroke symptoms often appear suddenly. The FAST (Face drooping, Arm weakness, Speech difficulties, Time to call emergency services) acronym is a well-known tool for recognizing stroke symptoms. However, other symptoms such as confusion, vision disturbances, and balance or coordination problems may also be indicative of a stroke.
Upon suspecting a stroke, immediate diagnostic measures should be taken. A CT scan or MRI of the brain is often the first step to confirm the diagnosis and differentiate between ischemic and hemorrhagic stroke. Additional tests like blood tests, carotid ultrasound, or cerebral angiogram may be required to identify the cause of the stroke.
Once a stroke is confirmed, swift initiation of treatment is crucial. For ischemic stroke, intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) can be given within 4.5 hours of symptom onset. In some cases, endovascular procedures may be considered. Hemorrhagic stroke management focuses on controlling bleeding and reducing pressure in the brain.
After initial management, secondary prevention strategies should be implemented to prevent recurrent strokes. This includes control of risk factors such as hypertension, diabetes, and atrial fibrillation, lifestyle modifications, and potentially antithrombotic therapy.
Early recognition and prompt management of stroke can significantly alter patient outcomes. As healthcare professionals, staying abreast of the latest diagnostic and treatment strategies is vital for providing optimal patient care in these critical situations.
1.
Talquetamab Combos Show Survival Benefit in r/r Myeloma
2.
From sweetener to cancer fighter? Fermented stevia shows promise in pancreatic cancer study
3.
Year in Review: Non-Small Cell Lung Cancer
4.
FINAL USPSTF RECOMMENDATIONS ON ANXIETY, DEPRESSION, AND SUIICIDAL RISK.
5.
Liposomal Chemo Combination No Better Than Standard Induction in Pediatric AML
1.
Targeted Therapies for Breast Cancer: What’s New?
2.
Ultrasound: A Promising Tool in the Fight Against Malignant Breast Cancer
3.
Adjuvant Atezolizumab in TNBC: What Recent Trials Reveal About Its Role
4.
Revolutionizing Cancer Care: The Transformative Role of AI and Data Science in Oncology
5.
Sorafenib: Understanding the science behind a powerful cancer drug
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
4.
Common Cancer Myths Debunked
5.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation